Home › UFLEX › Filing
🔔 Get instant alerts when UFLEX files quarterly results on BSE Start free trial →
UFLEX Limited (UFLEX)

Updates on Company's participation in 'Arihant Capital's Bharat Connect Conference: Rising Stars - September 2026'

Filed: 29 Sep 2026, 18:47 IST Exchange: BSE Category: General Update — Investor Presentation
Investor presentation shared for participation in Arihant Capital's Bharat Connect Conference on Sep 30, 2026, 11:00 AM IST - No unpublished price sensitive information to be shared - Company overview: 1.4 million MTPA global capacity, 21 plants across 9 countries - Q1 FY27 revenue Rs 53,972 Mn (+37.6% YoY), EBITDA Rs 9,198 Mn (+92.1% YoY) - Capex Rs 4,782 Mn in Q1 FY27 across Egypt, Mexico, Noida, Dharwad projects - Focus on aseptic, WPP, recycling investments to enhance growth and margins - Strong global presence with diversified product portfolio and customer base - FY26 revenue Rs 155,130 Mn, EBITDA Rs 19,097 Mn, 15.5% EBITDA margin
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 UFLEX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add UFLEX to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on UFLEX Limited

Important. The summary above is generated automatically from UFLEX Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.